HRC-Hainan Holding Co., LLC, et al v. Yihan Hu, et al
Case Number:
20-15371
Court:
Nature of Suit:
-
November 09, 2020
9th Circ. Urged To Nix Private Commercial Arbitration Doc Bid
Allowing investors who were ousted from a Chinese in vitro fertilization clinic project to seek documents for a $20 million arbitration would violate the United States' obligations under two international treaties, the former owner of a Chinese hospital told the Ninth Circuit.
-
July 22, 2020
Investors Say 9th Circ. Should OK Doc Bid In Hospital Fight
Three investors ousted from a Chinese hospital project who are seeking documents for a $20 million arbitration told the Ninth Circuit that a recent Second Circuit decision saying U.S. law doesn't let federal courts order discovery for private commercial arbitration abroad is irrelevant and wrong.
-
June 29, 2020
9th Circ. Told To Dig Into 'Tribunal' Meaning In Discovery Fight
The former owner of a Chinese hospital has further urged the Ninth Circuit to block an "intrusive and unwarranted" discovery order to hand over documents in a $20 million arbitration initiated by three investors ousted from an in vitro fertilization project.
-
June 05, 2020
Chinese Investors Urge 9th Circ. To Uphold Discovery Order
Three investors ousted from a Chinese in vitro fertilization project who seek documents for a $20 million arbitration they initiated have told the Ninth Circuit that a U.S. law allowing federal courts to order discovery for certain foreign proceedings extends to private commercial arbitration abroad.
-
May 05, 2020
9th Circ. Told It Can't Order Discovery For Private Arbitration
The former owner of a Chinese hospital is urging the Ninth Circuit to rule that Congress never intended for private arbitration abroad to be included within the scope of a U.S. law allowing federal courts to order discovery for certain foreign proceedings.
-
March 31, 2020
9th Circ. Lifts Stay In Soured IVF Center Deal Dispute
The Ninth Circuit has lifted a temporary stay of a subpoena issued to the former owner of a Chinese hospital, forcing her to turn over information to be used in arbitration and litigation in China by investors who claim they were wrongfully ousted from an in vitro fertilization clinic venture.